Home > Publications database > Composites of ceramic high-temperature proton conductors with inorganic compounds > print |
001 | 45393 | ||
005 | 20200423204109.0 | ||
024 | 7 | _ | |a 10.1149/1.1865592 |2 DOI |
024 | 7 | _ | |a WOS:000228326500006 |2 WOS |
024 | 7 | _ | |a 1099-0062 |2 ISSN |
024 | 7 | _ | |a 1944-8775 |2 ISSN |
024 | 7 | _ | |a 2128/2882 |2 Handle |
037 | _ | _ | |a PreJuSER-45393 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 540 |
084 | _ | _ | |2 WoS |a Electrochemistry |
084 | _ | _ | |2 WoS |a Materials Science, Multidisciplinary |
100 | 1 | _ | |a Schober, T. |b 0 |u FZJ |0 P:(DE-Juel1)VDB3067 |
245 | _ | _ | |a Composites of ceramic high-temperature proton conductors with inorganic compounds |
260 | _ | _ | |a Pennington, NJ |b Soc. |c 2005 |
300 | _ | _ | |a A199 - A200 |
336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a article |2 DRIVER |
440 | _ | 0 | |a Electrochemical and Solid State Letters |x 1099-0062 |0 13562 |y 4 |v 8 |
500 | _ | _ | |a Record converted from VDB: 12.11.2012 |
520 | _ | _ | |a This open-label extension evaluated the long-term efficacy and tolerability of rufinamide in patients with Lennox-Gastaut syndrome (LGS) who had previously completed a 12-week double-blind study.In total, 124 patients (aged 4-37 years), receiving 1-3 concomitant antiepileptic drugs, were treated with rufinamide approximately 25-60 mg/kg/day. Efficacy was assessed by seizure frequency; tolerability by adverse events (AEs) and laboratory tests.Overall, patients were treated with rufinamide for a median (range) of 432 (10-1149) days. Reductions in seizure frequency were observed throughout the study; during the last 12 months of treatment, 41.0% and 47.9% of patients had > or = 50% reduction in total and tonic-atonic seizure frequency, respectively. The most common AEs were vomiting (30.6%) and pyrexia (25.8%).In this open-label extension, rufinamide appeared to be an effective long-term adjunctive therapy for the treatment of LGS-associated seizures in children and young adults. |
536 | _ | _ | |a Kondensierte Materie |c M02 |2 G:(DE-HGF) |0 G:(DE-Juel1)FUEK242 |x 0 |
588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
650 | _ | 7 | |a J |2 WoSType |
773 | _ | _ | |a 10.1149/1.1865592 |g Vol. 8, p. A199 - A200 |p A199 - A200 |q 8 |t Electrochemical and solid-state letters |v 8 |y 2005 |x 1099-0062 |
856 | 7 | _ | |u http://dx.doi.org/10.1149/1.1865592 |u http://hdl.handle.net/2128/2882 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/45393/files/68987.pdf |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/45393/files/68987.jpg?subformat=icon-1440 |x icon-1440 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/45393/files/68987.jpg?subformat=icon-180 |x icon-180 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/45393/files/68987.jpg?subformat=icon-640 |x icon-640 |y OpenAccess |
909 | C | O | |o oai:juser.fz-juelich.de:45393 |p openaire |p open_access |p driver |p VDB |p dnbdelivery |
913 | 1 | _ | |k M02 |v Kondensierte Materie |l Kondensierte Materie |b Materie |0 G:(DE-Juel1)FUEK242 |x 0 |
914 | 1 | _ | |y 2005 |
915 | _ | _ | |0 StatID:(DE-HGF)0010 |a JCR/ISI refereed |
915 | _ | _ | |2 StatID |0 StatID:(DE-HGF)0510 |a OpenAccess |
920 | 1 | _ | |k IFF-IEM |l Elektronische Materialien |d 31.12.2006 |g IFF |0 I:(DE-Juel1)VDB321 |x 0 |
970 | _ | _ | |a VDB:(DE-Juel1)68987 |
980 | _ | _ | |a VDB |
980 | _ | _ | |a JUWEL |
980 | _ | _ | |a ConvertedRecord |
980 | _ | _ | |a journal |
980 | _ | _ | |a I:(DE-Juel1)PGI-7-20110106 |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a FullTexts |
980 | 1 | _ | |a FullTexts |
981 | _ | _ | |a I:(DE-Juel1)PGI-7-20110106 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|